News Posts List
Scientists Awarded Grants To Study Cancer Cures
07/22/2014
Dr. Andre Khalil of the University of Maine, studying breast cancer and Dr. Leif Oxburgh from Maine Medical Center Research Institute, studying kidney cancer, each received nearly $180,000 to further their research.
Metabolic enzyme stops progression of kidney cancer
07/21/2014
An enzyme called FBP1 -- essential for regulating metabolism -- binds to a transcription factor in the nucleus of certain kidney cells and restrains energy production in the cell body, researchers report.
University of Houston researchers create new method to draw molecules from live cells
07/18/2014
Technique using magnetic nanomaterials offers promise for diagnosis, gene therapy
Immunotherapy for Kidney Cancer
07/18/2014
Immunotherapy, a type of treatment designed to enhance or restore the body’s ability to fight cancerous cells by activating the immune system, has long been a mainstay of treatment for kidney cancer, and continues to attract considerable attention from oncologists and patients alike. The attention is not only due to the clinical benefits that patients continue to experience with immunotherapy, but also to the apparent promise of newer immunotherapeutic agents that are currently being investigated in clinical trials.
Football squad raises $131K at annual Lift For Life
07/13/2014
“To see the impact that we make on the families around the area, with kidney cancer families, is always very rewarding,” tight end Adam Breneman said.
Information Regarding Compound Medicine
07/06/2014
Many well-known pharmacy benefit managers and insurance companies, including Express Scripts, Catamaran, Optum, United HealthCare, and BCBS of various states, have made major changes to their coverage of prescribed compounded medicines.
A Clinical Trial For Kidney Cancer
06/27/2014
Dr. Robert Figlin describes a clinical trial for patients with advanced disease.
Podcast: About Kidney Cancer
06/27/2014
Prof. Dr. Marniza Saad, Associate Professor and Consultant Oncologist at University Malaya Medical Centre
MET is a potential target across all papillary renal cell carcinomas
06/17/2014
Recent report of MET inhibition strengthened the role of c–Met inhibition across pRCC.
Case Study: Observation in Metastatic RCC
06/14/2014
Brian I. Rini, MD, presents a case study focused on the treatment of a 64 year-old male who presented with recurrent lung nodules 9 years after a left radical nephrectomy for a clear-cell renal cell carcinoma (RCC).
News Feed